Inventor · disambiguated record
Jacob Glanville
Also filed as: GLANVILLE JACOB · GLANVILLE JACOB E · GLANVILLE JACOB E GUNN · GLANVILLE JACOB ELI GUNN
21 granted patents·14 pending applications·120 citations·filing 2012–2024
94Inventor score
Files withCENTIVAX INC12DISTRIBUTED BIO INC7CHARLES RIVER LABORATORIES INC4CRISPR THERAPEUTICS AG2PANDION OPERATIONS INC2
Top patents by PatentIndex Score
35 records- 0193US11407837B2GPCR binding proteins and synthesis thereofTWIST BIOSCIENCE CORP·Filed 2018·Granted Aug 9, 2022·11 cites·10 claims
- 0293US11028167B1Anti-SARS-Cov-2 antibodies derived from 3bgfCENTIVAX INC·Filed 2020·Granted Jun 8, 2021·11 cites·21 claims
- 0393US11021531B1Anti-SARS-Cov-2 antibodies derived from 2GHWCENTIVAX INC·Filed 2020·Granted Jun 1, 2021·17 cites·16 claims
- 0492US11053304B1Anti-SARS-Cov-2 antibodies derived from 6nb6CENTIVAX INC·Filed 2020·Granted Jul 6, 2021·10 cites·21 claims
- 0592US11028150B1Anti-SARS-CoV-2 antibodies derived from 2DD8CENTIVAX INC·Filed 2020·Granted Jun 8, 2021·7 cites·21 claims
- 0692US11021532B1Superhuman anti-SARS-CoV-2 antibodies and uses thereofCENTIVAX INC·Filed 2020·Granted Jun 1, 2021·9 cites·17 claims
- 0792US10899843B2Compositions and methods for the depletion of CD117+ cellsMAGENTA THERAPEUTICS INC·Filed 2018·Granted Jan 26, 2021·8 cites·38 claims
- 0891US11034762B1Anti-SARS-Cov-2 antibodies derived from CR3022CENTIVAX INC·Filed 2020·Granted Jun 15, 2021·4 cites·13 claims
- 0991US10196427B2Epitope focusing by variable effective antigen surface concentrationDISTRIBUTED BIO INC·Filed 2017·Granted Feb 5, 2019·6 cites·20 claims
- 1090US10202640B2Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencingUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Feb 12, 2019·20 cites·21 claims
- 1190US9884893B2Epitope focusing by variable effective antigen surface concentrationDISTRIBUTED BIO INC·Filed 2013·Granted Feb 6, 2018·5 cites·33 claims
- 1290US2025145668A1Epitope focusing by variable effective antigen surface concentrationCENTIVAX INC·Filed 2024·Application pending·0 cites
- 1389US10836797B2Epitope focusing by variable effective antigen surface concentrationDISTRIBUTED BIO INC·Filed 2018·Granted Nov 17, 2020·2 cites·17 claims
- 1486US11560409B2Epitope focusing by variable effective antigen surface concentrationCENTIVAX INC·Filed 2020·Granted Jan 24, 2023·1 cites·22 claims
- 1584US12043647B2Epitope focusing by variable effective antigen surface concentrationCENTIVAX INC·Filed 2022·Granted Jul 23, 2024·0 cites·15 claims
- 1684US11958908B2Compositions and methods for the depletion of CD117+ cellsCRISPR THERAPEUTICS AG·Filed 2020·Granted Apr 16, 2024·1 cites·26 claims
- 1783US10125198B2Method for mass humanization of non-human antibodiesDISTRIBUTED BIO INC·Filed 2016·Granted Nov 13, 2018·3 cites·11 claims
- 1883US8715673B2Staphylococcus aureus specific antibodies and uses thereofRINAT NEUROSCIENCE CORP·Filed 2012·Granted May 6, 2014·4 cites·15 claims
- 1979US11124581B2Method for mass humanization of non-human antibodiesCHARLES RIVER LABORATORIES INC·Filed 2018·Granted Sep 21, 2021·1 cites·12 claims
- 2078US2024360238A1Compositions and methods for the depletion of cd117+ cellsCRISPR THERAPEUTICS AG·Filed 2024·Application pending·0 cites
- 2170US2025002582A1Targeted immunotolerance with a pd-1 agonistPANDION OPERATIONS INC·Filed 2024·Application pending·0 cites
- 2266US2024044047A1Radically diverse human antibody libraryCHARLES RIVER LABORATORIES INC·Filed 2023·Application pending·0 cites
- 2366US2022281989A1Gpcr binding proteins and synthesis thereofTWIST BIOSCIENCE CORP·Filed 2022·Application pending·0 cites
- 2463US12460018B2System for generating immunoglobulin scaffolds for grafting non-human CDR amino acid sequencesALEGRE USA LLC·Filed 2021·Granted Nov 4, 2025·0 cites·14 claims
- 2563US2024294618A1Anti-venom antibodies and uses thereofCENTIVAX INC·Filed 2023·Application pending·0 cites
- 2661US2024270825A1Anti-sars-cov-2 antibodies derived from cr3022CENTIVAX INC·Filed 2023·Application pending·0 cites
- 2758US2021079066A1Radically diverse human antibody libraryDISTRIBUTED BIO INC·Filed 2020·Application pending·0 cites
- 2856US2022186209A1Methods of antibody panning against target proteinsCHARLES RIVER LABORATORIES INC·Filed 2022·Application pending·0 cites
- 2954US2021206856A1Targeted immunotolerance with a pd-1 agonistPANDION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3050US2021147566A1Antibodies and uses thereofDISTRIBUTED BIO INC·Filed 2020·Application pending·0 cites
- 3149US2021060126A1Major histocompatibility complex (mhc) compositions and methods of use thereofDISTRIBUTED BIO INC·Filed 2020·Application pending·0 cites
- 3249US2022088175A1Optimized vaccine compositions and methods for making the sameCENTIVAX INC·Filed 2021·Application pending·0 cites
- 3349US2022154171A1Antigen binding molecules and methods of screening thereofCHARLES RIVER LABORATORIES INC·Filed 2022·Application pending·0 cites
- 3446US11739146B2MAdCAM targeted immunotolerancePANDION OPERATIONS INC·Filed 2020·Granted Aug 29, 2023·0 cites·9 claims
- 3525US11685773B2Method for mass humanization of rabbit antibodiesABCHECK S R O·Filed 2016·Granted Jun 27, 2023·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Jacob Glanville files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →